US 11208416
Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
granted A61KA61K31/7064A61P
Quick answer
US patent 11208416 (Selective inhibitors of protein arginine methytransterase 5 (PRMT5)) held by Prelude Therapeutics, Incorporated expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/7064, A61P, A61P35/02